000			01962 a2200649 4500
005			20250515112531.0
264		0	_c20081229
008			200812s 0 0 eng d
022			_a1473-1150
024	7		_a10.1038/tpj.2008.1 _2doi
040			_aNLM _beng _cNLM
100	1		_aFilopanti, M
245	0	0	_aDopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas. _h[electronic resource]
260			_bThe pharmacogenomics journal _cOct 2008
300			_a357-63 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenoma _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAlleles
650	0	4	_aCabergoline
650	0	4	_aCross-Sectional Studies
650	0	4	_aDopamine Agonists _xtherapeutic use
650	0	4	_aErgolines _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGene Frequency
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPituitary Neoplasms _xdrug therapy
650	0	4	_aPolymorphism, Genetic
650	0	4	_aProlactin _xmetabolism
650	0	4	_aReceptors, Dopamine D2 _xgenetics
650	0	4	_aRetrospective Studies
700	1		_aBarbieri, A M
700	1		_aAngioni, A R
700	1		_aColao, A
700	1		_aGasco, V
700	1		_aGrottoli, S
700	1		_aPeri, A
700	1		_aBaglioni, S
700	1		_aFustini, M F
700	1		_aPigliaru, F
700	1		_aMonte, P D
700	1		_aBorretta, G
700	1		_aAmbrosi, B
700	1		_aJaffrain-Rea, M L
700	1		_aGasperi, M
700	1		_aBrogioni, S
700	1		_aCannavò, S
700	1		_aMantovani, G
700	1		_aBeck-Peccoz, P
700	1		_aLania, A
700	1		_aSpada, A
773	0		_tThe pharmacogenomics journal _gvol. 8 _gno. 5 _gp. 357-63
856	4	0	_uhttps://doi.org/10.1038/tpj.2008.1 _zAvailable from publisher's website
999			_c17834920 _d17834920